Cite
HARVARD Citation
Lin, A. et al. (2016). Clinical and research priorities for combined modality therapy in stage III NSCLC. Lung cancer management. pp. 43-50. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lin, A. et al. (2016). Clinical and research priorities for combined modality therapy in stage III NSCLC. Lung cancer management. pp. 43-50. [Online].